Pacira | PCRX - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Astellas Pharma JPY 158.38B 28.94B 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Cara Therapeutics USD 0 0 2025-03
Coherus Biosciences USD 4.04M 324K 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
J&J USD 8B 67M 2026-06
Ligand Pharmaceuticals USD 11.31M 59K 2026-06
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novo Nordisk DKK 17.1B 3.5B 2026-06
Omeros USD 33.16M 18.52M 2024-06
Pacira USD 58.49M 7.75M 2026-06
Perrigo USD 708.9M 65.2M 2026-06
Pfizer USD 4.09B 498M 2026-06
Supernus Pharmaceuticals USD 59M 9.97M 2026-06
Teva Pharmaceutical Industries USD 1.98B 30M 2026-06
Xeris Pharmaceuticals USD 10.57M 3.08M 2026-03
Zoetis USD 704M 32M 2026-06